This activity has been designed to meet the educational needs of oncology and radiation oncology specialists globally, including gynaecologic oncologists and oncology nurse specialists involved in the management of cervical cancer.
USF Health adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.
Prof. Bradley Monk discloses: Consultant fees from Agenus Inc., Akeso Biopharma Inc., Aravive Inc., AstraZeneca, Clovis Oncology, Eisai Co. Ltd., Elevar, EMD Serono, Genmab/Seagen, GOG Foundation, Gradalis Inc., ImmunoGen Inc., Karyopharm Therapeutics, Iovance Biotherapeutics, Merck, Mersana Therapeutics, Novocure, Myriad Genetics, Pfizer, Puma Biotechnology, Regeneron Pharmaceuticals, Inc., Roche/Genentech Inc., Sorrento Therapeutics, TESARO/GlaxoSmithKline, US Oncology Research and VBL. Speaker’s bureau fees from AstraZeneca, Clovis Oncology, Eisai Co. Ltd., Merck, Roche/Genentech Inc. and TESARO/GlaxoSmithKline. Grants/Research Support from US Oncology Research.
Prof. Cyrus Chargari discloses: Advisory board fees from GlaxoSmithKline and Merck Sharp & Dohme (both relationships terminated). Grants/research support fees from Roche.
Dr Mary McCormack discloses: Advisory board fees from AstraZeneca, Eisai Co Ltd., GlaxoSmithKline, Merck Sharp & Dohme and Roche.
Ms Kathleen Smith discloses No relevant financial disclosures in relation to this educational activity.
Mitchel S. Hoffman, MD has no financial interests/relationships or affiliations in relation to this activity
Touch Medical Director
Kathy Day has no financial interests/relationships or affiliations in relation to this activity.
USF Health Office of Continuing Professional Development and touchIME staff have no financial interests/relationships or affiliations in relation to this activity.
Requirements for Successful Completion
In order to receive credit for this activity, participants must review the content and complete the post-test and evaluation form. Statements of credit are awarded upon successful completion of the post-test and evaluation form.
If you have questions regarding credit please contact firstname.lastname@example.org
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of USF Health and touchIME. USF Health is accredited by the ACCME to provide continuing medical education for physicians.
USF Health designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The European Union of Medical Specialists (UEMS) – European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 CreditTM into European CME credit (ECMEC) should contact the UEMS (www.uems.eu)
Advanced Practice Providers
Physician Assistants may claim a maximum of 0.75 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.
The AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM by ACCME-accredited providers. APRNs who participate will receive a certificate of completion commensurate with the extent of their participation.
Date of original release: 31 March 2022. Date credits expire: 31 March 2023.
If you have any questions regarding credit please contact email@example.com